Physician profile
Katie Lenning
NPI 1831854595
$1,720.54
in general payments reported to CMS, 2019-2025
19 companies · $274 in 2025
The $274 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $265 · 2023: $357 · 2024: $824 · 2025: $274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,371 · Education: $83.64.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,371.42 |
| Education | $83.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $314.98 | 2023-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $296.92 | 2022-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $175.80 | 2022-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $168.30 | 2022-2024 | Jardiance |
| Chiesi USA, INC. | $129.14 | 2023-2025 | Kengreal |
| Novartis Pharmaceuticals Corporation | $97.37 | 2023-2025 | |
| Pfizer INC. | $82.78 | 2022-2024 | |
| Amgen INC. | $67.07 | 2024 | Repatha |
| Impulse Dynamics (USA) INC. | $60.84 | 2022-2025 | Optimizer, Optimizer |
| Kestra Medical Technology Services, INC. | $55.24 | 2024-2025 | Assure Wcd |
| Kiniksa Pharmaceuticals International, Plc | $50.67 | 2024 | Arcalyst |
| Scpharmaceuticals INC. | $39.75 | 2024-2025 | |
| Cardiva Medical, INC. | $38.70 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f, Optowire |
| Abiomed | $36.75 | 2024 | Impella |
| Daxor Corporation | $36.32 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $27.57 | 2023 | |
| Angiodynamics, INC. | $15.08 | 2025 | Bioflo |
| Lexicon Pharmaceuticals, INC. | $14.21 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katie Lenning listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.